BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  SQI Diagnostics Reports First Quarter 2018 Results

  SQI Diagnostics, today reported its financial and operational results for the three months ended December 31, 2017.

  February 5, 2018

   · 

  8 min read
• Biotech Beach

  Biocept Receives Additional Patent Issuances in Three Major International Territories for its Target Selector Platform

  In Japan, Biocept’s patent no. 6234817 is entitled METHODS AND REAGENTS FOR SIGNAL AMPLIFICATION, and in Europe, Biocept’s patent no. 2995953 is entitled DEVICES AND METHODS OF CELL CAPTURE AND ANALYSIS.

  February 5, 2018

   · 

  4 min read
• Drug Development

  Eribulin Mesylate Nearly Doubles Overall Survival in Previously Treated Patients with Advanced Liposarcoma in Subanalysis Published in the Journal of Clinical Oncology

  This preplanned subanalysis of the LPS subgroup in Study 309 supported the FDA approval of Halaven in patients with advanced liposarcoma.

  February 5, 2018

   · 

  11 min read
• 

  Deals

  Varian Snaps Up Privately-Held Mobius Medical Systems

  The deal expands the company’s Quality Assurance tool portfolio.

  February 5, 2018

   · 

  2 min read
• Policy

  Trethera Announces FDA Clearance of Investigational New Drug Application for TRE-515

  Under this IND, Trethera plans to initiate a Phase 1 study designed to evaluate the safety, pharmacokinetics, and pharmacodynamics of TRE-515 as well as validate several biomarkers in relapsed and/or refractory MDS patients who have no available alternative therapy.

  February 5, 2018

   · 

  3 min read
• Biotech Beach

  Endologix, Inc. Completes Patient Enrollment in the ELEVATE IDE Clinical Study

  Endologix announced today the completion of enrollment in the Expanding Patient Applicability with Polymer Sealing Ovation Alto Stent Graft (ELEVATE) IDE clinical study.

  February 5, 2018

   · 

  4 min read
• Lone Star Bio

  AngioSoma Announces Completion of Products for Market

  We are pleased to announce we are launching a line of supplements under our SomaceuticalsTM common identity to be marketed on our upcoming website to be named soma-ceuticals.com.

  February 5, 2018

   · 

  2 min read
• 

  Deals

  Bay Area’s Dextera Filed for Ch. 11 in Dec., Sells Assets to Aesculap

  The transaction is expected to be completed by February 20, 2018.

  February 5, 2018

   · 

  3 min read
• Business

  FLX Bio Adds Distinguished Biopharma Industry Leader Michael Giordano, M.D., to Board of Directors

  FLX Bio today announced the appointment of senior pharmaceutical research and development executive Michael F. Giordano, M.D., to its Board of Directors.

  February 5, 2018

   · 

  3 min read
• Biotech Beach

  Second Sight Announces Record Number of Argus II Retinal Prosthesis Systems Implants and Completes First-in-Human Orion Cortical Implant

  Second Sight provided an update on several key performance metrics, demonstrating the Company’s continued progress in executing its near- and long-term goals.

  February 5, 2018

   · 

  7 min read